Literature DB >> 8951315

A population-based study on the incidence of dementia disorders between 85 and 88 years of age.

O Aevarsson1, I Skoog.   

Abstract

OBJECTIVE: To investigate the incidence of Alzheimer's disease, vascular dementia and other dementias in a population between 85 and 88 years of age.
DESIGN: Prospective cohort study. Longitudinal population study of the very old.
SETTING: Systematic sample of a birth cohort living in the community or in institutions in the city of Gothenburg, Sweden. PARTICIPANTS: A representative population sample of nondemented 85-year-old residents (n = 347). MEASUREMENTS: The study included neuropsychiatric, neuropsychological, and physical examinations, key informant interviews, comprehensive laboratory tests, electrocardiography, chest radiography and computed tomography (CT-scan) of the head. Information on subjects lost during the follow-up period as a result of death or refusal was traced in medical records. Dementia was defined according to the criteria proposed in the Diagnostic and Statistical Manual of Mental Disorders (3rd Edition, revised), Alzheimer's disease according to the criteria of the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association, and vascular dementia according to criteria proposed by Erkinjuntti.
RESULTS: Sufficient information was obtained about 92% of the subjects at risk. Sixty-three subjects (18.2%) became demented between ages 85 and 88, giving an incidence of 90.1/1000/year (61.3/1000/year for men and 102.7/1000/ year for women; P = .085). The incidence of Alzheimer's disease was 36.3/1000/year, vascular dementia 39.0/1000/ year (P = 1.000), and that of other dementias 9.1/1000/year.
CONCLUSION: This study shows that almost one-tenth of nondemented persons between the ages of 85 and 88 become demented each year, emphasizing the magnitude of the dementia problem in the very old, the fastest growing segment of western populations.

Entities:  

Mesh:

Year:  1996        PMID: 8951315     DOI: 10.1111/j.1532-5415.1996.tb04070.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  9 in total

1.  A Swedish programme for dementia diagnostics in primary healthcare.

Authors:  Erik Jedenius; Anders Wimo; Jan Strömqvist; Niels Andreasen
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

2.  [White matter lesions as a risk factor for stroke and dementia. A population-based study in 85-year-olds].

Authors:  M Liebetrau; G F Hamann; I Skoog
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

3.  A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality.

Authors:  I Skoog; C Hesse; O Aevarsson; S Landahl; J Wahlström; P Fredman; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

Review 4.  Epidemiology of Alzheimer disease.

Authors:  Richard Mayeux; Yaakov Stern
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

Review 5.  Worldwide prevalence and incidence of dementia.

Authors:  L Fratiglioni; D De Ronchi; H Agüero-Torres
Journal:  Drugs Aging       Date:  1999-11       Impact factor: 4.271

6.  Impact of neuroprotection on incidence of Alzheimer's disease.

Authors:  Raúl de la Fuente-Fernández
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

Review 7.  Epidemiology and Risk Factors of Alzheimer's Disease in Iran: A Systematic Review.

Authors:  Elham Navipour; Mahbobeh Neamatshahi; Zahra Barabadi; Mohammad Neamatshahi; Aghilallah Keykhosravi
Journal:  Iran J Public Health       Date:  2019-12       Impact factor: 1.429

8.  Pathology and pathogenesis of vascular cognitive impairment-a critical update.

Authors:  Kurt A Jellinger
Journal:  Front Aging Neurosci       Date:  2013-04-10       Impact factor: 5.750

9.  Cost-effectiveness of drug therapies for Alzheimer's disease: A brief review.

Authors:  David S Geldmacher
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.